BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 31518679)

  • 1. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.
    Gao J; Fan K; Jin Y; Zhao L; Wang Q; Tang Y; Xu H; Liu Z; Wang S; Lin J; Lin D
    Eur J Pharm Sci; 2019 Dec; 140():105070. PubMed ID: 31518679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic/organic platform for the effective treatment of multidrug resistant breast cancer.
    Dong Y; Liao H; Yu J; Fu H; Zhao D; Gong K; Wang Q; Duan Y
    J Nanobiotechnology; 2019 Dec; 17(1):125. PubMed ID: 31870362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle.
    Samykutty A; Grizzle WE; Fouts BL; McNally MW; Chuong P; Thomas A; Chiba A; Otali D; Woloszynska A; Said N; Frederick PJ; Jasinski J; Liu J; McNally LR
    Biomaterials; 2018 Nov; 182():114-126. PubMed ID: 30118979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.
    Butler KS; Durfee PN; Theron C; Ashley CE; Carnes EC; Brinker CJ
    Small; 2016 Apr; 12(16):2173-85. PubMed ID: 26780591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoexpulsion of surface-grafted ruthenium complexes and subsequent release of cytotoxic cargos to cancer cells from mesoporous silica nanoparticles.
    Frasconi M; Liu Z; Lei J; Wu Y; Strekalova E; Malin D; Ambrogio MW; Chen X; Botros YY; Cryns VL; Sauvage JP; Stoddart JF
    J Am Chem Soc; 2013 Aug; 135(31):11603-13. PubMed ID: 23815127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Curcumin's therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery.
    Radha R; Paul V; Anjum S; Bouakaz A; Pitt WG; Husseini GA
    Sci Rep; 2024 May; 14(1):10499. PubMed ID: 38714740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer.
    Liu X; Jiang J; Chan R; Ji Y; Lu J; Liao YP; Okene M; Lin J; Lin P; Chang CH; Wang X; Tang I; Zheng E; Qiu W; Wainberg ZA; Nel AE; Meng H
    ACS Nano; 2019 Jan; 13(1):38-53. PubMed ID: 30525443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo/Magnetocaloric therapy on MDA-MB-231 cells.
    Cai D; Liu L; Han C; Ma X; Qian J; Zhou J; Zhu W
    Sci Rep; 2019 Oct; 9(1):14475. PubMed ID: 31597929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size-Optimized Ultrasmall Porous Silica Nanoparticles Depict Vasculature-Based Differential Targeting in Triple Negative Breast Cancer.
    Goel S; Ferreira CA; Dogra P; Yu B; Kutyreff CJ; Siamof CM; Engle JW; Barnhart TE; Cristini V; Wang Z; Cai W
    Small; 2019 Nov; 15(46):e1903747. PubMed ID: 31565854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based mesoporous silica nanoparticles: a paradigm shift in management of pancreatic cancer.
    Bellapu KK; Joga R; Kannan BR; Yerram S; Varpe P; Mergu T; Vasu PY; Srivastava S; Kumar S
    Pharm Pat Anal; 2023 Nov; 12(6):261-273. PubMed ID: 38214201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched oligopeptides form nanocapsules with lipid vesicle characteristics.
    Sukthankar P; Gudlur S; Avila LA; Whitaker SK; Katz BB; Hiromasa Y; Gao J; Thapa P; Moore D; Iwamoto T; Chen J; Tomich JM
    Langmuir; 2013 Nov; 29(47):14648-54. PubMed ID: 24188529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural bioactive lysosomes extracted from multiple cells for tumor therapy.
    Zhang J; Xu Q; Zhang Y; Foda MF; Cai K; Liu Q; Jia F; Wang H; Xu F; Han H; Liang H
    Biomaterials; 2024 Jan; 304():122430. PubMed ID: 38100907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzyl Isothiocyanate Induces Apoptosis and Inhibits Tumor Growth in Canine Mammary Carcinoma via Downregulation of the Cyclin B1/Cdk1 Pathway.
    Cheng N; Diao H; Lin Z; Gao J; Zhao Y; Zhang W; Wang Q; Lin J; Zhang D; Jin Y; Bao Y; Lin D
    Front Vet Sci; 2020; 7():580530. PubMed ID: 33263014
    [No Abstract]   [Full Text] [Related]  

  • 14. Design of a Novel Nucleus-Targeted NLS-KALA-SA Nanocarrier to Delivery Poorly Water-Soluble Anti-Tumor Drug for Lung Cancer Treatment.
    Yan C; Shi W; Gu J; Lee RJ; Zhang Y
    J Pharm Sci; 2021 Jun; 110(6):2432-2441. PubMed ID: 33412169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous Silica Nanoparticles: Types, Synthesis, Role in the Treatment of Alzheimer's Disease, and Other Applications.
    Sivamaruthi BS; Kapoor DU; Kukkar RR; Gaur M; Elossaily GM; Prajapati BG; Chaiyasut C
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional mesoporous silica nanoparticles for biomedical applications.
    Xu B; Li S; Shi R; Liu H
    Signal Transduct Target Ther; 2023 Nov; 8(1):435. PubMed ID: 37996406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine.
    Kang C; Wang J; Li R; Gong J; Wang K; Wang Y; Wang Z; He R; Li F
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy.
    Huang M; Zhai BT; Fan Y; Sun J; Shi YJ; Zhang XF; Zou JB; Wang JW; Guo DY
    Int J Nanomedicine; 2023; 18():4275-4311. PubMed ID: 37534056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential - a review.
    Iranshahy M; Hanafi-Bojd MY; Aghili SH; Iranshahi M; Nabavi SM; Saberi S; Filosa R; Nezhad IF; Hasanpour M
    RSC Adv; 2023 Jul; 13(32):22250-22267. PubMed ID: 37492509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of Curcumin and Paclitaxel Co-Loaded Lipid Nano Platform and Evaluation of Its Anti-Hepatoma Activity in vitro and Pharmacokinetics in vivo.
    Wei Y; Wei Y; Sheng L; Ma J; Su Z; Wen J; Li L; Jia Q; Liu H; Si H; Xiong L; Chen J; Cheng J; Zuo Y; Yang H; Zhao L
    Int J Nanomedicine; 2023; 18():2087-2107. PubMed ID: 37122500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.